1. Israel Stocks

  2. •

    Financial Services

  3. •

    Asset Management
The Trendlines Group Ltd.

The Trendlines Group Ltd.

TRNLY
The Trendlines Group Ltd.US flagOther OTC
2.10
USD
- -
- -
40.42MMarket Cap
The Trendlines Group Ltd.
TRNLY
(Other OTC)

Recent

price

2.10

P/E

ratio

- -

div

yld

- -

ROIC.AI

2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
FRC
0.86
0.61
0.69
0.55
0.6
0.41
0.24
0.14
0.21
0.23
0.08
0.01
0.44
Revenue per Share
-0.41
-0.44
-0.63
0.36
-0.49
-0.04
-0.23
0.4
-0.84
-1.73
-0.46
0.08
-0.17
Basic EPS, GAAP
-1.02
-0.82
-0.86
-0.72
-0.69
-0.46
-0.21
- -
-0.87
-0.33
-0.43
-0.39
-0.69
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
3.92
3.35
1.77
2.1
1.32
1.23
0.79
1.2
0.3
-1.45
-1.84
-1.49
0.83
Book Value per Share
8.03
11.23
7.5
8.63
6.93
7.43
5.94
6.33
5.57
3.51
3.31
3.31
6.38
Tangible Book Value per Share
7
7
10
11
12
13
16
16
17
20
21
23
15
Basic Weighted Avg Shares
6
5
7
6
7
6
4
2
4
4
2
- -
7
Sales/Revenue/Turnover
-44.34
42.44
-149.24
89.02
-85.76
14.69
-426.38
-65.67
-346.2
-762.66
-622.69
22.29
-7.11
Operating Margin (%)
- -
- -
- -
- -
- -
1
1
1
1
1
1
1
1
Depreciation Expense
-3
-3
-7
4
-6
- -
-4
7
-14
-34
-9
2
-3
Net Income, GAAP
- -
- -
- -
29.47
- -
607.3
- -
- -
- -
- -
- -
- -
27.68
Effective Tax Rate (%)
-47.28
-72.31
-91.23
65.75
-81.79
-8.62
-97.14
285.22
-404.7
-756.12
-548.28
548
-40
Profit Margin (%)
- -
20
12
14
6
15
11
12
6
4
3
3
13
Working Capital
6
4
4
4
3
6
5
5
4
4
3
4
6
LT Debt
56
84
78
93
86
100
96
103
96
69
68
77
96
Total Equity
- -
- -
- -
4.11
- -
-4.2
- -
- -
- -
- -
- -
0.1
- -
Return on Invested Capital (%)
- -
- -
- -
15.19
- -
-5.49
- -
- -
- -
- -
- -
-7.54
5.61
Return on Capital (%)
- -
-12.63
-30.2
18.78
-31.26
-2.87
-25.4
40.73
-117.91
- -
- -
- -
-19.38
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Dec'19
Mar'20
Jun'20
ST Debt
- -
- -
1
LT Borrowings
4
- -
3
LT Finance Leases
2
- -
2
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
811
- -
811
Market Capitalization
43
39
68

Working Capital

FRC

•

in mil. unless spec.
Dec'19
Mar'20
Jun'20
Total Current Assets
20
- -
17
Cash, Cash Equivalents & STI
19
- -
8
Accounts Receivable, Net
- -
- -
1
Inventories
- -
- -
- -
Total Current Liabilities
5
- -
3
Payables & Accruals
- -
- -
- -
ST Debt
- -
- -
1
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
0.09%
-3.16%
13.7%
Free Cash Flow
-2,003.64%
-4,001.29%
1.87%
Net Income, GAAP
-37.65%
-130.85%
-120.35%
Sales/Revenue/Turnover
-9.01%
-20.08%
-79.64%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
4
2024
- -
- -
- -
- -
2
2025
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
-1.73
2024
- -
- -
- -
- -
-0.46
2025
- -
- -
- -
- -
0.08

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
- -
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
Similar Companies
Vanguard ESG Developed World All Cap Equity Index Fund (UK) GBP Acc (0P0001K1DP.L)
USCF SummerHaven SHPEN Index Fund (BUYN)
Pathfinder Focused Opportunities ETF (PFOE)
iPath Bloomberg Cocoa Subindex Total Return(SM) ETN (NIB)
Amundi ETF DAX UCITS ETF (DR) FCP (CG1.L)
iShares S&P/TSX Global Base Metals Index ETF (XBM.TO)
Business
The Trendlines Group Ltd. (SGX: 42T; OTCQX: TRNLY) serves as an Israel-based innovation commercialization company and private equity firm that invests in, incubates, and develops early-stage companies in medical technologies and agrifood technologies; its core activities encompass technology development, business building, R&D support, commercialization strategies, funding facilitation, and market access for portfolio firms across sectors including cardiology, neurology, urology, women's health, surgery, spine and orthopedics, crop protection, aquaculture, digitization, robotics, future foods, and net-zero technologies. The company operates through business units such as Trendlines Medical, Trendlines Agtech, Trendlines Medical Singapore, and Trendlines Labs, maintaining a portfolio exceeding 50 companies with select examples featuring devices for clot extraction in ischemic stroke, stress urinary incontinence alleviation, pelvic organ prolapse repair, bioactive coral-based bone grafts, phage-based crop protection solutions, natural food colors from yeast fermentation, AI-driven crop disease analytics, and cell-cultured cocoa ingredients; it provides hands-on services like business development, financial support, and marketing to entrepreneurs targeting global markets in healthcare and agriculture. Founded in 2007 and headquartered at 17 T'chelet Street, Misgav Business Park, Israel, with additional offices in Singapore, Tel Aviv, and formerly Beijing, the group leverages partnerships with investors, governments, and strategic players including Israel Innovation Authority grants to advance its mission of improving the human condition through seed-to-market progression. Recent developments include portfolio firm IBI Ag securing $6.1 million in Series A funding led by Corteva in 2025 with Trendlines participation, Arcuro Medical closing initial Series A led by Varana Capital involving Trendlines, EIC Fund co-financing for a women's health solution in June 2025, Phytolon achieving manufacturing efficiency milestones in May 2025, September 2025 strategic partnerships such as SOLVEAT-CBC alongside SEGER's FDA progress, Celleste Bio's cell-cultured cocoa butter milestone, and the cessation of CFO Igor Vatenmacher effective November 13, 2025; these activities alongside ongoing investments by Trendlines and Librae Holdings underscore portfolio momentum in regulatory approvals, capital raises, and technological advancements.

Company News

APIChatGPT

  • prnewswire.com

    NICE Surgical Awarded Additional Purse-String Stapler Associated U.S. Patent

  • prnewswire.com

    NICE Surgical Awarded U.S. Patent for Purse-String Stapler

  • schaeffersresearch.com

    2 Trendlines in Focus For Pfizer Stock After Earnings

  • prnewswire.com

    IBI Ag Announces Successful Development of AI-Driven De Novo Protein Design Platform for Bioinsecticides

  • schaeffersresearch.com

    Key Trendlines to Watch After S&P 500's New Records

  • fxempire.com

    Natural Gas and Oil Forecast: Rally Extends, but Descending Trendlines Cap Upside Potential

  • schaeffersresearch.com

    S&P 500 Trendlines to Watch as Bulls Remain in Control

  • prnewswire.com

    IBI Ag Completes $10 Million Series A Round Led by Corteva

  • fxempire.com

    Natural Gas and Oil Forecast: OPEC+ Hike and Trendlines Signal Further Weakness

  • prnewswire.com

    Escala Secures $4.5M in Funding to Accelerate Global Expansion of Its FDA-Approved Medical Device

  • investors.com

    Why Nvidia Stock Woos Investors With Trendlines, Not Headlines

  • fxempire.com

    Natural Gas and Oil Forecast: Trendlines Hold as Traders Eye $3.76 and $63.86

  • schaeffersresearch.com

    Sprouts Farmers Market Stock Nears 2 Bullish Trendlines

  • schaeffersresearch.com

    3 Resistance Trendlines Driving the S&P 500's Advance

  • prnewswire.com

    Arcuro Medical Announces FDA 510(k) Clearance for the SuperBall RC for Rotator Cuff Indications

  • prnewswire.com

    Limaca's Precision-GI™ Enters US Market

  • prnewswire.com

    IBI Ag Secures $6.1 Million in Funding Round Led by Corteva Inc.

  • prnewswire.com

    Varana Capital Leads Arcuro Medical's Series A Financing, Driving Strategic Growth in 2025

  • schaeffersresearch.com

    GE Aerospace Stock Could Bounce Off Bullish Trendlines

  • prnewswire.com

    Limaca's Precision-GI™ Granted CMS Transitional Pass-Through (TPT) Payment